Nce is specifically mediated by the 25bp region. Although promising, the results obtained using the 25-bpdeleted minigene -in which the pseudoexon has been shortened to 50 bp- might be partially affected by the intrinsic tendency of skipping of small exons [32]. To avoid this confounding effect and to confirm the splicing-enhancing activity of the 25-bp region, a fine mapping of specific enhancer elements was performed. In particular, further dissection of hnRNP F binding sites within thewhole FGG pseudoexon, by multiple small deletions removing the G-run elements, 11089-65-9 manufacturer nicely confirmed that the G2 element is a 
splicing enhancer, whereas the G1 and G3 motifs act as canonical ESS (Figure 5). Moreover, a second functional purine-rich element within the 25-bp region was found, which might cooperate with 
the enhancer G2-run in hnRNP F responsiveness. Interestingly, the two identified ESEs were functional only in HepG2 cells, revealing a cell-type specific regulation of pseudoexon splicing. This might be dependent, at least in part, on the difference in hnRNP F levels between the two analyzed cell models (Figure S4A), although the involvement of additional hepato-specific transacting factors cannot be ruled out. Indeed, when hnRNP F was overexpressed in HepG2, we obtained, for all M mutant constructs, a response more similar to that obtained in HeLa in basal condition (Figure S4B), suggesting that the fine regulation of splicing factor levels in different cell lines is important to modulate the amount of pseudoexon recognition by the splicing machinery. Concerning the question of how the G-runs or hnRNP F increase exon-definition, recent reports have suggested that G-stretches near to donor sites may act co-operatively to recruit U1snRNA, either through direct binding or through other splicing factors [33]. This effect, however, was shown to be critically dependent on the proximity of the G-run to the splice site. In our case, considering the distance between the G2 element and the 59 splice site of FGG pseudoexon, this possibility is rather unlikely. Alternatively, we can speculate that our G-runs may also mediate direct binding of U2AF35 to the 39 splice site of the pseudoexon, a possibility that would be interesting to test in the future. Taken together, these results highlight several important issues with regards to splicing regulation. First of all, the importance of always checking experimentally, whenever possible, the transacting factors binding to in-silico predicted elements. Although insilico methods are constantly improving, there is still a major gap between predicted and actual binding sites, as shown in our pulldown experiments. A second consideration regards the importance of not making too close a parallelism between the presence of a specific regulator and its potential effects on the inclusion (or exclusion) of any pre-mRNA sequence in the mature transcript. Indeed, our data suggest that hnRNP F can act either as activator or as repressor of pseudoexon inclusion through the binding of different cis-acting elements. Finally, 16574785 this study highlights the intrinsic complexity of the splicing process, even in sequences that are not subjected to evolutionary pressure (Figure S1B).Salmon calcitonin site Materials and Methods PlasmidsThe minigene construct pT-FGG-IVS6-320A.T, containing the mutant IVS6-320A.T human FGG genomic region spanning from intron 4 to intron 7 (based on GenBank accession number NG_008834), was previously described [17]. The deletion m.Nce is specifically mediated by the 25bp region. Although promising, the results obtained using the 25-bpdeleted minigene -in which the pseudoexon has been shortened to 50 bp- might be partially affected by the intrinsic tendency of skipping of small exons [32]. To avoid this confounding effect and to confirm the splicing-enhancing activity of the 25-bp region, a fine mapping of specific enhancer elements was performed. In particular, further dissection of hnRNP F binding sites within thewhole FGG pseudoexon, by multiple small deletions removing the G-run elements, nicely confirmed that the G2 element is a splicing enhancer, whereas the G1 and G3 motifs act as canonical ESS (Figure 5). Moreover, a second functional purine-rich element within the 25-bp region was found, which might cooperate with the enhancer G2-run in hnRNP F responsiveness. Interestingly, the two identified ESEs were functional only in HepG2 cells, revealing a cell-type specific regulation of pseudoexon splicing. This might be dependent, at least in part, on the difference in hnRNP F levels between the two analyzed cell models (Figure S4A), although the involvement of additional hepato-specific transacting factors cannot be ruled out. Indeed, when hnRNP F was overexpressed in HepG2, we obtained, for all M mutant constructs, a response more similar to that obtained in HeLa in basal condition (Figure S4B), suggesting that the fine regulation of splicing factor levels in different cell lines is important to modulate the amount of pseudoexon recognition by the splicing machinery. Concerning the question of how the G-runs or hnRNP F increase exon-definition, recent reports have suggested that G-stretches near to donor sites may act co-operatively to recruit U1snRNA, either through direct binding or through other splicing factors [33]. This effect, however, was shown to be critically dependent on the proximity of the G-run to the splice site. In our case, considering the distance between the G2 element and the 59 splice site of FGG pseudoexon, this possibility is rather unlikely. Alternatively, we can speculate that our G-runs may also mediate direct binding of U2AF35 to the 39 splice site of the pseudoexon, a possibility that would be interesting to test in the future. Taken together, these results highlight several important issues with regards to splicing regulation. First of all, the importance of always checking experimentally, whenever possible, the transacting factors binding to in-silico predicted elements. Although insilico methods are constantly improving, there is still a major gap between predicted and actual binding sites, as shown in our pulldown experiments. A second consideration regards the importance of not making too close a parallelism between the presence of a specific regulator and its potential effects on the inclusion (or exclusion) of any pre-mRNA sequence in the mature transcript. Indeed, our data suggest that hnRNP F can act either as activator or as repressor of pseudoexon inclusion through the binding of different cis-acting elements. Finally, 16574785 this study highlights the intrinsic complexity of the splicing process, even in sequences that are not subjected to evolutionary pressure (Figure S1B).Materials and Methods PlasmidsThe minigene construct pT-FGG-IVS6-320A.T, containing the mutant IVS6-320A.T human FGG genomic region spanning from intron 4 to intron 7 (based on GenBank accession number NG_008834), was previously described [17]. The deletion m.
